David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
GE Aerospace
GE
|
+$570M |
| 2 |
Meta Platforms (Facebook)
META
|
+$469M |
| 3 |
TWX
Time Warner Inc
TWX
|
+$342M |
| 4 |
Merck
MRK
|
+$322M |
| 5 |
MON
Monsanto Co
MON
|
+$249M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$434M |
| 2 |
Netflix
NFLX
|
+$301M |
| 3 |
Alibaba
BABA
|
+$245M |
| 4 |
Verizon
VZ
|
+$235M |
| 5 |
Tesla
TSLA
|
+$230M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.95% |
| 2 | Healthcare | 11.57% |
| 3 | Consumer Discretionary | 9.23% |
| 4 | Communication Services | 8.8% |
| 5 | Industrials | 7.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CSRA
451
DELISTED
CSRA Inc.
CSRA
| $34.3M | 0.05% |
1,147,331
-330,723
| -22% | -$10M |
|
|
MRSH
452
Marsh
MRSH
$91.6B
| $34.2M | 0.05% |
420,323
-95,901
| -19% | -$7.97M |
|
453
Edwards Lifesciences
EW
$51.8B
| $34M | 0.05% |
905,007
+176,835
| +24% | +$6.49M |
|
454
Carter's
CRI
$1.31B
| $33.9M | 0.05% |
288,702
-77,812
| -21% | -$8.06M |
|
455
MSC Industrial Direct
MSM
$6.69B
| $33.9M | 0.05% |
350,790
-147,991
| -30% | -$12.4M |
|
456
AerCap
AER
$23B
| $33.9M | 0.05% |
643,874
+185,107
| +40% | +$9.64M |
|
457
PUT
Trip.com Group
TCOM
$29B
| $33.6M | 0.05% |
762,800
+559,400
| +275% | +$26.7M |
|
|
ANTX
458
DELISTED
Anthem, Inc.
ANTX
| $33.6M | 0.05% |
+600,000
| New | +$32.6M |
|
|
AMED
459
DELISTED
Amedisys
AMED
| $33.6M | 0.05% |
637,517
+134,151
| +27% | +$7.07M |
|
|
TMX
460
DELISTED
Terminix Global Holdings, Inc.
TMX
| $33.6M | 0.05% |
977,339
+694,916
| +246% | +$22.4M |
|
461
PUT
Bausch Health
BHC
$2.41B
| $33.4M | 0.05% |
1,608,900
-153,200
| -9% | -$2.43M |
|
462
CMS Energy
CMS
$21.4B
| $33.3M | 0.05% |
704,869
+445,690
| +172% | +$21.6M |
|
463
CALL
FedEx
FDX
$76.9B
| $33.3M | 0.05% |
133,600
-66,400
| -33% | -$15.2M |
|
464
Commault Systems
CVLT
$5.55B
| $33.3M | 0.05% |
634,519
+111,823
| +21% | +$6.19M |
|
465
Ecolab
ECL
$78.9B
| $33.3M | 0.05% |
248,018
-3,708
| -1% | -$493K |
|
466
Pentair
PNR
$10.3B
| $33.2M | 0.05% |
700,061
+636,120
| +995% | +$29.7M |
|
467
Norfolk Southern
NSC
$78.8B
| $33.1M | 0.05% |
228,356
+175,954
| +336% | +$23.6M |
|
468
Baxter International
BAX
$13.6B
| $32.9M | 0.05% |
509,439
+215,508
| +73% | +$13.8M |
|
469
Newell Brands
NWL
$2.59B
| $32.9M | 0.05% |
1,063,937
+1,052,944
| +9,578% | +$36.3M |
|
|
BNY
470
Bank of New York Mellon
BNY
$108B
| $32.7M | 0.05% |
607,662
+282,574
| +87% | +$15.1M |
|
471
Brunswick
BC
$5.24B
| $32.5M | 0.04% |
588,675
-60,035
| -9% | -$3.27M |
|
472
Bio-Rad Laboratories Class A
BIO
$10.2B
| $32.5M | 0.04% |
136,202
+124,666
| +1,081% | +$30.2M |
|
473
Coca-Cola
KO
$392B
| $32.5M | 0.04% |
707,358
-1,568,709
| -69% | -$72.1M |
|
474
Entergy
ETR
$48.8B
| $32.2M | 0.04% |
791,104
-265,984
| -25% | -$11.1M |
|
475
TE Connectivity
TEL
$58.9B
| $32.2M | 0.04% |
338,729
-163,016
| -32% | -$15M |
|
Similar funds
David Shaw's Q4 2017 Portfolio in Review
As of Q4 2017, David Shaw held 3,940 positions worth $72.6B, up 12% from $65.1B the previous quarter. Its ten largest holdings account for 9.5% of the portfolio.
David Shaw deployed $3.73B of net new capital in Q4 2017, opening 507 new positions and adding to 1,441 existing holdings. Its largest new stake was iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019: 3,178,870 shares worth $88.8M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 14% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was Apple, an estimated $434M trimmed.
- David Shaw's largest Q4 2017 buy was iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019: 3,178,870 shares worth $88.8M.
- David Shaw added most to GE Aerospace in Q4 2017, an estimated $570M increase.
- David Shaw's biggest Q4 2017 reduction was Apple, cutting an estimated $434M.
- David Shaw fully exited Tesla in Q4 2017, selling an estimated $230M.
- David Shaw's ten largest holdings make up 9.5% of its $72.6B portfolio in Q4 2017.
- David Shaw opened 507 new positions and closed 394 in Q4 2017.
- David Shaw's portfolio value rose 12% quarter-over-quarter to $72.6B.
Based on D.E. Shaw & Co's 13F filing for Q4 2017, filed 14 Feb 2018.